首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1
【24h】

Hepatotoxicity in Rats Induced by Aqueous Extract of Polygoni Multiflori Radix, Root of Polygonum multiflorum Related to the Activity Inhibition of CYP1A2 or CYP2E1

机译:多边形多氟菌的水提取物诱导的大鼠肝毒性,与CYP1A2或CYP2E1的活性抑制有关的多谷族多核的根

获取原文
获取原文并翻译 | 示例
           

摘要

The objective of this study is to investigate the relationship between the hepatotoxicity induced by Polygoni Multiflori Radix (PMR, root of Polygonum multiflorum Thunb., He Shou Wu) and the activity of CYP1A2 or CYP2E1 in the rat liver. Levels of rat serum transaminases ALT and AST were not altered but the activity of CYP1A2 or CYP2E1 in the rat liver was significantly inhibited after oral administration of aqueous extract of PMR under the experimental dosage. However, levels of ALT and AST were significantly increased and the activity of CYP1A2 or CYP2E1 was significantly decreased after injection of specific inhibitor for CYP1A2 or CYP2E1 combined with oral administration of aqueous extract of PMR, especially under the repeated treatment over interval times. Liver histopathological observation showed that a moderate liver injury occurred in rats receiving PMR treatment with the activity of CYP1A2 or CYP2E1 inhibited, but there was no significant liver damage in rats receiving PMR treatment or CYP inhibitor alone. These suggested that low level activity of CYP1A2 or CYP2E1 from genetic polymorphism among people might be one of the important reasons for the hepatotoxicity induced by PMR in clinical practice.
机译:本研究的目的是探讨由多功能多氟化糖(PMR,多谷氨酸多叶植物ThUnB的PMR的肝毒性与大鼠肝脏中CYP1A2或CYP2E1的活性之间的关系。大鼠血清转氨酶Alt和AST没有改变,但在实验剂量下PMR的水提取物口服施用后,大鼠肝脏中CYP1A2或CYP2E1的活性显着抑制。然而,在注射CYP1A2或CYP2E1的特定抑制剂与口服施用PMR水提取物中,CYP1A2或CYP2E1的活性显着增加,CYP1A2或CYP2E1的活性显着降低,特别是在间隔时间重复处理。肝脏组织病理学观察表明,在接受PMR处理的大鼠中发生中度肝损伤,CYP1A2或CYP2E1抑制的活性,但在接受PMR治疗或CYP抑制剂的大鼠中没有显着的肝脏损伤。这些表明,人们之间的CYP1A2或CYP2E1的低水平活性可能是PMR在临床实践中诱导的肝毒性的重要原因之一。

著录项

  • 来源
  • 作者单位

    Beijing Univ Chinese Med Sch Chinese Mat Med 6 Wang Jing Zhong Huan Nan Lu Beijing 100102;

    Beijing Univ Chinese Med Sch Chinese Mat Med 6 Wang Jing Zhong Huan Nan Lu Beijing 100102;

    Beijing Univ Chinese Med Sch Chinese Mat Med 6 Wang Jing Zhong Huan Nan Lu Beijing 100102;

    Beijing Univ Chinese Med Sch Chinese Mat Med 6 Wang Jing Zhong Huan Nan Lu Beijing 100102;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 临床医学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号